The dressing uses Imbed’s synthetic matrix to deliver ionic and metallic silver along with lidocaine to manage wounds such as venous stasis ulcers, pressure ulcers, ischemic ulcers, partial thickness burns, donor site wounds, surgical wounds, post-operative incisions, abrasions and lacerations.

The product will be launched in May. It was approved by the Food and Drug Administration, which in 2016 approved the company’s previous product, Microlyte Ag, for sale as a medical device. The wound-healing film was invented in 2008 by a team at UW-Madison that included Ankit Agarwal, co-founder and chief scientific officer of the company.